NCT00099944View on ClinicalTrials.gov

Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

515

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

vildagliptin

DRUG

Glimepiride

Glimepiride 4 mg qd

DRUG

LAF237 placebo

Trial Locations (1)

07936

Novartis Pharmaceuticals, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY